Sagimet Biosciences Inc. Quarterly Operating Lease, Liability, Current in USD from Q4 2022 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.
Summary
Sagimet Biosciences Inc. quarterly Operating Lease, Liability, Current history and growth rate from Q4 2022 to Q3 2024.
  • Sagimet Biosciences Inc. Operating Lease, Liability, Current for the quarter ending September 30, 2024 was $116K, a 12.6% increase year-over-year.
Operating Lease, Liability, Current, Quarterly (USD)
Operating Lease, Liability, Current, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 $116K +$13K +12.6% Sep 30, 2024 10-Q 2024-11-14
Q2 2024 $153K +$13K +9.29% Jun 30, 2024 10-Q 2024-08-14
Q1 2024 $26K Mar 31, 2024 10-Q 2024-05-15
Q4 2023 $65K -$68K -51.1% Dec 31, 2023 10-Q 2024-11-14
Q3 2023 $103K Sep 30, 2023 10-Q 2023-11-13
Q2 2023 $140K Jun 30, 2023 10-Q 2023-08-21
Q4 2022 $133K Dec 31, 2022 10-K 2024-03-25
* An asterisk sign (*) next to the value indicates that the value is likely invalid.